Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 21,366 shares at $148.55 ($3.1M) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Open-market sale of $3.1M WGS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.93 | 369 | $51K | 1.7% |
| 2 | $138.93 | 369 | $51K | 1.7% |
| 3 | $140.08 | 1,031 | $144K | 4.7% |
| 4 | $140.08 | 1,031 | $144K | 4.7% |
| 5 | $140.95 | 356 | $50K | 1.6% |
| 6 | $140.95 | 356 |
| $50K |
| 1.6% |
| 7 | $141.20 | 2,679 | $378K | 12.3% |
| 8 | $141.20 | 2,679 | $378K | 12.3% |
| 9 | $142.12 | 604 | $86K | 2.8% |
| 10 | $142.12 | 604 | $86K | 2.8% |
| 11 | $144.27 | 940 | $136K | 4.4% |
| 12 | $144.27 | 940 | $136K | 4.4% |
| 13 | $145.36 | 1,628 | $237K | 7.7% |
| 14 | $145.36 | 1,628 | $237K | 7.7% |
| 15 | $146.93 | 1,970 | $289K | 9.4% |
| 16 | $146.93 | 1,970 | $289K | 9.4% |
| 17 | $148.55 | 932 | $138K | 4.5% |
| 18 | $148.55 | 932 | $138K | 4.5% |
| 19 | $149.20 | 274 | $41K | 1.3% |
| 20 | $150.75 | 74 | $11K | 0.4% |
| Total | $143.79 avg | 21,366 | $3.1M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |